Taken together, these results indicate that circulating bacterial DNA is bioactive and capable of driving systemic immune activation in susceptible hosts and, in particular, the IFN-γ signature we previously observed in patients with CVID and inflammatory complications. This evidence concerns the gene IFNG and common variable immunodeficiency.